A systematic review of bevacizumab efficacy in breast cancer
Author:
Publisher
Elsevier BV
Subject
Radiology Nuclear Medicine and imaging,Oncology,General Medicine
Reference128 articles.
1. Hallmarks of cancer: the next generation;Hanahan;Cell,2011
2. Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer;Ferrara;Nat Rev Drug Discov,2004
3. Vascular endothelial growth factor (VEGF) as a target of bevacizumab in cancer: from the biology to the clinic;Ranieri;Curr Med Chem,2006
4. A phase II trial of docetaxel with bevacizumab as first-line therapy for HER2-negative metastatic breast cancer (TORI B01);Hurvitz;Clin Breast Cancer,2010
5. Phase II trial of bevacizumab in combination with weekly docetaxel in metastatic breast cancer patients;Ramaswamy;Clin Cancer Res,2006
Cited by 63 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Proteomics appending a complementary dimension to precision oncotherapy;Computational and Structural Biotechnology Journal;2024-12
2. 3D bioprinted breast cancer model reveals stroma-mediated modulation of extracellular matrix and radiosensitivity;Bioactive Materials;2024-12
3. Mechanistic insights into cisplatin response in breast tumors: Molecular determinants and drug/nanotechnology-based therapeutic opportunities;Mutation Research - Reviews in Mutation Research;2024-07
4. An integrated omics approach highlights how epigenetic events can explain and predict response to neoadjuvant chemotherapy and bevacizumab in breast cancer;Molecular Oncology;2024-04-26
5. Decellularized plant-derived vasculature-on-a-chip interacting with breast cancer spheroids to evaluate a dual-drug therapy;Applied Materials Today;2024-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3